In malignancies such as ovarian [15] and pancreatic cancer [16], MUC16 CTD translocation drives the expression of invasion-related genes, such as NRP2 in pancreatic cancer, promoting disease progression. This evidence concerns the gene MUC16 and pancreatic neoplasm.